273 related articles for article (PubMed ID: 29991464)
21. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
Spanakis E; Milord E; Gragnoli C
J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
[TBL] [Abstract][Full Text] [Related]
22. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
[TBL] [Abstract][Full Text] [Related]
23. A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.
Zhang M; Yu Q; Chen C; Han J; Cheng B; Tian D
Medicine (Baltimore); 2019 Apr; 98(17):e15348. PubMed ID: 31027113
[TBL] [Abstract][Full Text] [Related]
24. A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.
Abaci A; Wood K; Demir K; Büyükgebiz A; Böber E; Kopp P
Endocr Pract; 2010; 16(2):231-6. PubMed ID: 19703807
[TBL] [Abstract][Full Text] [Related]
25. A novel splicing mutation in the V2 vasopressin receptor.
Kamperis K; Siggaard C; Herlin T; Nathan E; Hertz JM; Rittig S
Pediatr Nephrol; 2000 Nov; 15(1-2):43-9. PubMed ID: 11095010
[TBL] [Abstract][Full Text] [Related]
26. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.
Sasaki S; Chiga M; Kikuchi E; Rai T; Uchida S
Clin Exp Nephrol; 2013 Jun; 17(3):338-44. PubMed ID: 23150186
[TBL] [Abstract][Full Text] [Related]
27. Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree.
Bai Y; Chen Y; Kong X
BMC Nephrol; 2018 Feb; 19(1):26. PubMed ID: 29394883
[TBL] [Abstract][Full Text] [Related]
28. Clinical and Functional Characterization of a Novel Mutation in
Guo S; Wu S; Li Z; Huang L; Zhan D; Zhang C; Luo X
Front Pediatr; 2021; 9():790194. PubMed ID: 34956990
[No Abstract] [Full Text] [Related]
29. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
30. A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.
Ashida A; Yamamoto D; Nakakura H; Matsumura H; Uchida S; Sasaki S; Tamai H
Pediatr Nephrol; 2007 May; 22(5):670-3. PubMed ID: 17216256
[TBL] [Abstract][Full Text] [Related]
31. Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus.
Dong Y; Sheng H; Chen X; Yin J; Su Q
BMC Genet; 2006 Nov; 7():53. PubMed ID: 17101063
[TBL] [Abstract][Full Text] [Related]
32. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
Wildin RS; Cogdell DE; Valadez V
Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
[TBL] [Abstract][Full Text] [Related]
33. A patient with congenital nephrogenic diabetes insipidus due to AVPR2 mutation complicated by persisting polydipsia under hemodialysis treatment.
Iijima T; Mori T; Sohara E; Suwabe T; Hoshino J; Ubara Y
CEN Case Rep; 2021 May; 10(2):226-229. PubMed ID: 33125666
[TBL] [Abstract][Full Text] [Related]
34. A novel missense mutation in the AVPR2 gene of a Japanese infant with nephrogenic diabetes insipidus.
Takatani T; Matsuo K; Kinoshita K; Takatani R; Minagawa M; Kohno Y
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):415-8. PubMed ID: 20583549
[TBL] [Abstract][Full Text] [Related]
35. Novel mutations underlying nephrogenic diabetes insipidus in Arab families.
Carroll P; Al-Mojalli H; Al-Abbad A; Al-Hassoun I; Al-Hamed M; Al-Amr R; Butt AI; Meyer BF
Genet Med; 2006 Jul; 8(7):443-7. PubMed ID: 16845277
[TBL] [Abstract][Full Text] [Related]
36. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
[TBL] [Abstract][Full Text] [Related]
38. Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.
Li Q; Tian D; Cen J; Duan L; Xia W
J Endocrinol Invest; 2021 Dec; 44(12):2777-2783. PubMed ID: 34101133
[TBL] [Abstract][Full Text] [Related]
39. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
Bichet DG; Turner M; Morin D
Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
